This study compares p16 INK4a immunohistochemistry (IHC), HPV chromogenic in situ hybridization (ISH), and HPV polymerase chain reaction (PCR) genotyping for detection of HPV infection in basaloid squamous carcinoma (BSCC). A retrospective histopathological analysis of 40 BSCC from a single institution was carried out. p16 IHC, HPV DNA extraction and ISH, and HPV PCR genotyping were performed, and there was excellent agreement between all 3 methods of HPV detection. Analysis of variance yielded no significant differences between the results of the 3 tests ( P = .354) and Pearson product—moment correlation coefficients calculated for each pair of tests demonstrated direct correlation (r = .61 for PCR and IHC, r = .61 for PCR and ISH, and r = 1.00 for ISH and IHC). This supports the use of p16INK4a IHC as an initial screening tool for HPV infection in BSCC, while definitive evidence of HPV DNA can be sought subsequently with PCR or CISH.
Dell G., Gaston K.Human papillomaviruses and their role in cervical cancer. Cell Mol Life Sci. 2001;58:1923-1942.
4.
Klussmann JP , Mooren JJ, Lehnen M., et al. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res. 2009;15:1779-1786.
5.
Strati K., Pitot HC, Lambert PFIdentification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model . Proc Natl Acad Sci U S A. 2006;103:14152-14157.
6.
Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst . 2000;92:709-720.
7.
Gillison ML , D’Souza G., Westra W., et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers . J Natl Cancer Inst. 2008;100:407-420.
8.
Nichols AC, Faquin WC, Westra WH, et al. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2009;140:228-234.
9.
Lassen P., Eriksen JG, Hamilton-Dutoit S., Tramm T., Alsner J., Overgaard J.Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol. 2009;27:1992-1998.
10.
Hafkamp HC, Mooren JJ, Claessen SM, et al. P21(Cip1/ WAF1) expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod Pathol . 2009;22:686-698.
11.
Weinberger PM, Yu Z., Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol. 2006 ;24:736-747.
12.
Fakhry C., Westra WH, Li S., et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
13.
Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2465-2472.
14.
Szentirmay Z., Polus K., Tamas L., et al. Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations . Cancer Metastasis Rev. 2005;24:19-34.
15.
Wain SL, Kier R., Vollmer RT, Bossen EHBasaloid-squamous carcinoma of the tongue, hypopharynx, and larynx: report of 10 cases. Hum Pathol. 1986;17:1158-1166.
16.
Begum S., Westra WHBasaloid squamous cell carcinoma of the head and neck is a mixed variant that can be further resolved by HPV status. Am J Surg Pathol . 2008;32:1044-1050.
17.
El-Mofty SK , Patil S.Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype . Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101:339-345.
18.
Kurman RJ, Toki T., Schiffman MHBasaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol. 1993;17:133-145.
19.
Santos M., Landolfi S., Olivella A., et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol. 2006;30:1347-1356.
20.
Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MCThe biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma: molecular basis and predicting favorable outcome. Mod Pathol. 2008;21:376-386.
21.
Lewis JS Jr , Thorstad WL, Zhang J., Yip JH, El Mofty SKClinical significance of p16 positive but HPV negative oropharyngeal squamous cell carcinoma. Mod Pathol . 2010;23(Suppl1):1236A.
22.
Winters R., Naud S., Evans MF, et al. Ber-EP4, CK1, CK7 and CK14 are useful markers for basaloid squamous carcinoma. A study of 45 cases. Head Neck Pathol. 2008;2:265-271.
23.
Evans MF, Aliesky HA, Cooper K.Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens . BMC Clin Pathol. 2003;3:2.
24.
Campisi G., Giovannelli F.Controversies surrounding human papillomavirus infection, head and neck vs oral cancer, implications for prophylaxis and treatment. Head Neck Oncol. 2009;1:8.
25.
Snijders PJF , van den Brule AJ, Meijer Cjlm.The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol. 2003;201:1-6.
26.
Smeets SJ, Hesselink AT, Speel EJM, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer. 2007;121:2645-2672.
27.
Smith EM, Ritchie JM, Summersgill KF, et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst. 2004;96:449-455.
28.
Matsukura T. , Sugase M.Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. Int J Gynecol Cancer . 2008;18:1042-1050.
29.
Terai M., Hashimoto K., Yoda K., Sata T.High prevalence of human papillomaviruses in the normal oral cavity of adults . Oral Microbiol Immunol. 1999;14:201-205.
30.
Braakhuis BJM , Snijders PJF, Keune WJH, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus . J Natl Cancer Inst. 2004;96:998-1006.
31.
Kong CS, Balzer BL, Troxell ML, Patterson BK, Longacre TAP16INK4a immunohistochemistry is superior to HPV in situ hybridization for detection of high-risk HPV in atypical squamous metaplasia. 2007;31:33-43.
32.
Bernard JE, Butler MO, Sandweiss L., Weidner N.Anal intraepithelial neoplasia: correlation of grade with p16INK4a immunohistochemistry and HPV in situ hybridization. Appl Immunohistochem Mol Morphol . 2008;16: 215-220.
